CAROLYN BARRETT: Open Payments
NPI 1629335336 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,858 in 95 payments from 25 companies in 2025. Trend: 2023 $2,179 · 2024 $1,959 · 2025 $1,858
Food & beverage: $1,858
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $289 |
| ABBVIE INC. | 17 | $272 |
| AstraZeneca Pharmaceuticals LP | 9 | $199 |
| Lilly USA, LLC | 7 | $133 |
| Lundbeck LLC | 4 | $105 |
| PFIZER INC. | 5 | $89 |
| Astellas Pharma US Inc | 4 | $78 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Amgen Inc. | 4 | $62 |
Products named: Wegovy, FARXIGA, VRAYLAR, VYEPTI, MOUNJARO, Veozah, UBRELVY, SHINGRIX.
Industry payments across DE — which companies pay providers there.
